Follikuláris limfóma: vizsgálatok itt: Norvégia

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  Where

  Bergen, Oslo, Toensberg, Trondheim

  Életkor

  18 év and over

  People

  270 worldwide

  Run by

  Karolinska University Hospital

  See details and how to join2023-508196-36-00
• 2. fázisTaking people
  Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

  Where

  Oslo, Trondheim

  Életkor

  18 év and over

  People

  80 worldwide

  Run by

  Oslo University Hospital

  See details and how to joinNCT05849857